Litigation Details for Genus Lifesciences Inc. v. Lannett Company, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Genus Lifesciences Inc. v. Lannett Company, Inc. (D. Del. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-06-08 |
| Court | District Court, D. Delaware | Date Terminated | 2021-10-20 |
| Cause | 35:1 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | |
| Parties | LANNETT COMPANY, INC. | ||
| Patents | 10,016,407; 10,149,843; 10,231,961; 10,413,505; 10,420,760; 9,867,815 | ||
| Attorneys | Julia Chapman | ||
| Firms | KL Gates LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Genus Lifesciences Inc. v. Lannett Company, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Genus Lifesciences Inc. v. Lannett Company, Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-06-08 | 1 | Complaint | This is an action for patent infringement of U.S. Patent Nos. 9,867,815; 10,016,407; and 10,420,760 (collectively…. 15. United States Patent No. 10,016,407 (the “’407 patent”), titled “Pharmaceutical Compositions… THE PATENTS-IN-SUIT 12. United States Patent No. 9,867,815 (the “’815 patent”), titled…collectively, “the Patents-in-Suit”) under the patent laws of the United States, Title 35, United States…1338 because this is a patent infringement action that arises under the patent laws of the United States | External link to document |
| 2020-07-24 | 14 | Declaration | –18 of U.S. Patent No. 9,867,815; and claims 2–5 and 12–15 of U.S. Patent No. 10,016,407 arising from…2020 20 October 2021 1:20-cv-00770 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2020-08-28 | 28 | Brief - Reply | 10,016,407 (“the ’407 patent”); and claims 1, 4, 7–12, 15, and 18–20 of U.S. Patent No. 10,420,760 (“… U.S. Patent No. 9,867,815 (“the ’815 patent”); claims 1, 6, 9-11, 16, 19, and 20 of U.S. Patent No. 10,016,407…of the ’815 patent and claims 2–5, and 12–15 of the ’407 patent, (2) the Unasserted Patents, and (3) C-Topical…Genus sued Lannett for patent infringement on specific claims of three patents.1 In response, Lannett …(“the ’760 patent”) (collectively, “the Asserted Patents” and “the Asserted Claims”). 2 Lannett’s Memorandum | External link to document |
| 2020-06-08 | 3 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,867,815 B1 ;10,016,407 B1 ;10,420,…2020 20 October 2021 1:20-cv-00770 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2021-03-23 | 59 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,867,815 ;10,016,407 ;10,420,760 ;…2020 20 October 2021 1:20-cv-00770 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2020-06-19 | 6 | Counterclaim AND Answer to Complaint | infringement of U.S. Patent Nos. 9,867,815 (the “’815 Patent”), 10,016,407 (the “’407 Patent”), and 10,420,…claims of the ’815 Patent, the ’407 Patent, the ’760 Patent, and United States Patent Nos. 10,149,843 … valid claim of any of the ’815 Patent, ’407 Patent, or ’760 Patent. Lannett otherwise denies the allegations…any valid claim of the ’815 Patent, the ’407 Patent, or the ’760 Patent, literally or by equivalents,…Invalidity. Each claim of the ’815 Patent, the ’407 Patent, and the ’760 Patent is invalid for failure to satisfy | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
